MarketCap
Facebook
X
Telegram
Evofem Biosciences EV/EBITDA | EVFM
EV/EBITDA Jährlich Evofem Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.3 | -11.7 | -4.36 | -1.14 | -5.55 | -1.99 | -3.65 | -0.969 | -1.74 | -0.574 | 0.316 | 5.51 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 26.3 | -11.7 | 0.0358 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Adaptimmune Therapeutics plc
ADAP
|
-2.47 | - | -15.15 % | $ 60.3 M |  Britain |
 |
MannKind Corporation
MNKD
|
34.4 | $ 4.22 | 0.84 % | $ 1.29 B |  USA |
 |
AVEO Pharmaceuticals
AVEO
|
-18.2 | - | - | $ 521 M | USA |
 |
MediciNova
MNOV
|
-3.2 | $ 1.4 | -4.76 % | $ 68.7 M | USA |
 |
Merck & Co.
MRK
|
97.3 | $ 147.75 | -0.68 % | $ 370 B | USA |
 |
Moderna
MRNA
|
-7.16 | $ 250.79 | -6.77 % | $ 97.6 B | USA |
 |
Axcella Health
AXLA
|
-0.295 | - | -16.42 % | $ 249 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.01 K | - | - | $ 2.02 B | USA |
 |
Intellia Therapeutics
NTLA
|
-1.83 | $ 11.18 | -7.72 % | $ 1.21 B | USA |
 |
Novartis AG
NVS
|
20.9 | $ 163.39 | -0.18 % | $ 317 B |  Schweiz |
 |
Omeros Corporation
OMER
|
-5.43 | $ 17.3 | -1.48 % | $ 1.1 B | USA |
 |
Oramed Pharmaceuticals
ORMP
|
-6.11 | $ 3.97 | -0.75 % | $ 164 M |  Israel |
 |
Tyme Technologies
TYME
|
0.228 | - | 8.07 % | $ 54 M | USA |
 |
Puma Biotechnology
PBYI
|
9.01 | $ 8.13 | -3.22 % | $ 407 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
-0.621 | $ 1.02 | -5.09 % | $ 47.3 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
-3.16 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Pfizer
PFE
|
41.7 | $ 29.34 | 0.36 % | $ 167 B | USA |
 |
Завод ДИОД
DIOD
|
7.12 | - | - | - |  Russia |
 |
PainReform Ltd.
PRFX
|
-0.255 | $ 0.78 | -4.24 % | $ 505 K | Israel |
 |
Prothena Corporation plc
PRTA
|
0.0485 | $ 8.56 | -2.51 % | $ 461 M | USA |
 |
Arcus Biosciences
RCUS
|
-5.18 | $ 18.66 | -1.56 % | $ 2 B | USA |
 |
Orgenesis
ORGS
|
-1.03 | - | -33.86 % | $ 61.2 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
2.14 | $ 14.9 | -1.03 % | $ 12.4 B |  India |
 |
Regeneron Pharmaceuticals
REGN
|
21.2 | $ 916.16 | -0.41 % | $ 95.8 B | USA |
 |
Replimune Group
REPL
|
-3.15 | $ 23.3 | 4.67 % | $ 2.16 B | USA |
 |
Фармсинтез
LIFE
|
-115 | - | - | - | Russia |
 |
Royalty Pharma plc
RPRX
|
18.1 | $ 69.47 | 1.02 % | $ 29.9 B | USA |
 |
Revolution Medicines
RVMD
|
-17 | $ 193.0 | -3.57 % | $ 36.7 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
-33.9 | $ 113.99 | 0.04 % | $ 7.41 B | USA |
 |
Codiak BioSciences
CDAK
|
-4.42 | - | -55.98 % | $ 2.15 M | USA |
 |
Sana Biotechnology
SANA
|
-4.97 | $ 2.43 | -1.42 % | $ 615 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
-26.8 | $ 61.81 | 0.11 % | $ 172 M | Israel |
 |
Summit Therapeutics
SMMT
|
81.3 K | $ 17.78 | -0.34 % | $ 13.3 B | Britain |
 |
Checkpoint Therapeutics
CKPT
|
-3.09 | - | - | $ 169 M | USA |
 |
Syndax Pharmaceuticals
SNDX
|
-7.7 | $ 9.43 | -0.89 % | $ 817 M | USA |
 |
Spero Therapeutics
SPRO
|
16.2 | $ 1.01 | -5.61 % | $ 56.6 M | USA |
 |
Sarepta Therapeutics
SRPT
|
-4.66 | $ 16.4 | -5.54 % | $ 1.64 B | USA |
 |
Tarsus Pharmaceuticals
TARS
|
-42.1 | $ 73.9 | 4.32 % | $ 3.09 B | USA |
 |
Bio-Techne Corporation
TECH
|
31.6 | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
-1.01 | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
5.02 | - | - | $ 1.62 B | Israel |
 |
Cabaletta Bio
CABA
|
-1.49 | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
-2.62 | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
414 | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
22.7 | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
0.497 | $ 4.12 | -8.35 % | $ 35.1 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
-8.54 | - | - | $ 121 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-18.7 | $ 11.55 | 4.52 % | $ 1.61 B |  France |
 |
Gilead Sciences
GILD
|
16.9 | $ 170.68 | 0.8 % | $ 212 B | USA |
 |
Taysha Gene Therapies
TSHA
|
-11.3 | $ 4.28 | -2.06 % | $ 1.37 B | USA |